Janc, J.; Suchański, M.; Mierzchała-Pasierb, M.; Woźnica-Niesobska, E.; Łysenko, L.; Leśnik, P.
Does the Serum Concentration of Angiotensin II Type 1 Receptor Have an Effect on the Severity of COVID-19? A Prospective Preliminary Observational Study among Healthcare Professionals. J. Clin. Med. 2022, 11, 1769.
https://doi.org/10.3390/jcm11071769
AMA Style
Janc J, Suchański M, Mierzchała-Pasierb M, Woźnica-Niesobska E, Łysenko L, Leśnik P.
Does the Serum Concentration of Angiotensin II Type 1 Receptor Have an Effect on the Severity of COVID-19? A Prospective Preliminary Observational Study among Healthcare Professionals. Journal of Clinical Medicine. 2022; 11(7):1769.
https://doi.org/10.3390/jcm11071769
Chicago/Turabian Style
Janc, Jarosław, Michał Suchański, Magdalena Mierzchała-Pasierb, Ewa Woźnica-Niesobska, Lidia Łysenko, and Patrycja Leśnik.
2022. "Does the Serum Concentration of Angiotensin II Type 1 Receptor Have an Effect on the Severity of COVID-19? A Prospective Preliminary Observational Study among Healthcare Professionals" Journal of Clinical Medicine 11, no. 7: 1769.
https://doi.org/10.3390/jcm11071769
APA Style
Janc, J., Suchański, M., Mierzchała-Pasierb, M., Woźnica-Niesobska, E., Łysenko, L., & Leśnik, P.
(2022). Does the Serum Concentration of Angiotensin II Type 1 Receptor Have an Effect on the Severity of COVID-19? A Prospective Preliminary Observational Study among Healthcare Professionals. Journal of Clinical Medicine, 11(7), 1769.
https://doi.org/10.3390/jcm11071769